Nevertheless, they found that increasingly severe phenotypes showed a significant decrease in plasma SOD activity, where the controls had the highest SOD activity, followed by female ALD patients, males with myelopathy, then cerebral ALD patients. Here, SOD1 is linked to Myelopathy.